Hyperinsulinemic response to oral glucose in obese patients with essential hypertension

Authors

  • N. A. Alaagib Department of Physiology, Faculty of Medicine, University of Khartoum
  • M. Y. Sukkar Nile College
  • M. M. Kardash Omdurman Ahlia University

Keywords:

Hyperinsulinemic, plasma glucose

Abstract

Background and objectives: Hypertension is a common health problem. The prevalence of hypertension
increases progressively with increasing Body Mass Index. The aim of this study is to investigate changes
in blood pressure (BP), plasma glucose (PG) and insulin level after ingestion of oral glucose; and to assess
the relation between insulin level and BP in obese and non-obese normo-tensive and hypertensive subjects.
Materials and Methods: Seventy five g glucose dissolved in 250 ml of water was given orally to 20 fasting
newly diagnosed untreated patients with essential hypertension and 15 normo-tenisve control subjects
matched for age, gender and Body Mass Index (BMI). Smokers and subjects with diabetes, hyperlipidemia,
cardiac or renal disease or those taking medications were excluded. Subjects were monitored for 2 hours.
Half hourly BP, PG and insulin were measured.
Results: Subjects were classified into obese (BMI≥ 30 Kg/m2) (11 patients, 8 normo-tensives) and
nonobese (BMI< 30 Kg/m2) (9 patients, 7 normo-tensives). In obese hypertensive patients, insulin showed
significant positive correlation with: systolic BP (SBP) (P=.04), diastolic BP (DBP) (P=.04) and mean BP
(MBP) (P=.03). Obese hypertensive patients showed a significantly higher insulin response to oral glucose
than obese normo-tensive subjects (P=.02).
In obese and non-obese hypertensive patients glucose intake was associated with significant drop in DBP
((P≤ .005), (P< .05)) and MBP ((P< .005), (P< .05)) respectively.
Conclusions: In obese hypertensive patients, the hyperinsulinemic response to oral glucose and the
positive correlation of insulin with BP suggest that insulin may be involved in development of essential
hypertension especially in obese patients.

Downloads

Published

2022-12-28